FOR IMMEDIATE RELEASE – October 31, 2025 AUSTIN, TX – Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELLED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09-30-2026 may incorrectly identify the product
Similar Posts
Chetak LLC Group Expands Voluntary Product Recall to Include Additional Frozen Vegetable and Fruit Products Due to Possible Health Risk
Collectively (“Chetak”) is expanding its voluntary recall, initiated July 16, 2025, to include several lots of Deep-branded frozen vegetables and fruit products due to possible Salmonella contamination. The recall is limited to frozen vegetable and fruit products as discussed further below.Products Containing 7-OH Can Cause Serious Harm
The FDA recommends that consumers avoid 7-OH products, including foods, dietary supplements and those claiming to treat an ailment or disorder. 7-OH is not approved as a drug by the FDA.Trividia Health, Inc. Initiates Voluntary Recall of Limited Number of TRUE METRIX® Blood Glucose Meters
(FT. LAUDERDALE, FL) –October 7, 2025 – Trividia Health, Inc., announced today that it is initiating a voluntary recall of a limited number of TRUE METRIX® Self-Monitoring Blood glucose meters co-branded under the Good Neighbor Pharmacy® brand and distributed in the United States.Early Alert: Convenience Kit Needle Issue from Integra LifeSciences
Integra LifeSciences is removing certain lots of Microsensor and Cerelink ICP Kits with potential corrosion stains on the included Tuohy Needle.Best Buy Bones, Inc. Recalls Nature’s Own Pet Chews Bully Bites Because of Possible Salmonella Health Risk
October 3, 2025, Best Buy Bones, Inc. of Mount Morris, Michigan is recalling four lots of Nature’s Own Pet Chews Bully Bites 1 Pound pet treats in 16 oz. bags with a shared expiration date of September 2027because it has the potential to be contaminated with Salmonella. Salmonella can affect animalsSelective Safety Data Collection (SSDC) Demonstration Project
Offers an innovative approach to facilitate the conduct of large-scale efficacy and safety trials through the purposeful reduction in the collection of certain types of data for drugs or biologics with a well-characterized safety profile.